VB-201 - VBL Therapeutics
VBL: Annual Report 2014 (VBL Therapeutics) - Apr 23, 2015 - Anticipated patent expiry in 2027 
Anticipated patent expiry • Immunology • Psoriasis
http://ir.vblrx.com/phoenix.zhtml?c=253311&p=irol-sec
 
Apr 23, 2015
 
.